10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $912M | $145M | 85.4% | 5.6% | $78M | — | $105M |
| 2024 | $803M | $54M | 84.7% | 4.5% | $91M | — | $150M |
| 2023 | $625M | -$21M | 84.5% | -6.4% | $1M | — | $186M |
| 2022 | $408M | -$45M | 83.8% | -11.7% | $2M | — | $442M |
| 2021 | $233M | -$42M | 85.7% | -17.1% | -$25M | $25M | $214M |
| 2020 | $115M | -$57M | 84.7% | -48.7% | -$56M | $25M | $191M |
| 2019 | $82M | -$33M | 83.4% | -42.5% | -$36M | $25M | $23M |
| 2018 | $51M | -$22M | 80.1% | -40.3% | -$19M | $25M | $97M |
| 2017 | — | -$18M | — | — | -$16M | — | $9M |
| 2016 | — | -$19M | — | — | -$18M | — | $7M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $205M | -$11M | 86.5% | -0.5% | $3M | — | $99M |
| Dec '25 | $269M | $136M | 86.6% | 17.1% | $42M | — | $105M |
| Sep '25 | $225M | $10M | 85.8% | 4.3% | $58M | — | $113M |
| Jun '25 | $217M | -$4M | 84.0% | -1.5% | -$6M | — | $107M |
| Mar '25 | $201M | $3M | 84.7% | -0.7% | -$15M | — | $54M |
| Dec '24 | $240M | $35M | 85.0% | 13.3% | $62M | — | $150M |
| Sep '24 | $203M | $18M | 84.1% | 7.0% | $44M | — | $148M |
| Jun '24 | $196M | $10M | 84.8% | 2.6% | -$12M | — | $188M |
| Mar '24 | $164M | -$10M | 84.9% | -9.3% | -$3M | — | $175M |
| Dec '23 | $193M | $15M | 85.4% | 4.8% | $9M | — | $186M |
| Sep '23 | $153M | -$9M | 84.1% | -8.8% | -$3M | — | $330M |
| Jun '23 | $151M | -$12M | 83.9% | -11.0% | $237000 | — | $467M |
| Mar '23 | $128M | -$15M | 84.4% | -15.2% | -$5M | — | $442M |
| Dec '22 | $138M | — | 83.9% | -0.2% | $16M | — | $442M |
| Sep '22 | $109M | -$17M | 81.9% | -15.7% | $7M | — | $418M |
| Jun '22 | $91M | -$14M | 84.5% | -15.3% | -$7M | $21M | $187M |
| Mar '22 | $69M | -$17M | 85.6% | -23.1% | -$14M | $25M | $203M |
| Dec '21 | $78M | — | 85.8% | -2.3% | $201000 | $25M | $214M |
| Sep '21 | $62M | -$10M | 86.0% | -15.9% | -$1M | $25M | $210M |
| Jun '21 | $53M | -$13M | 85.8% | -23.7% | -$12M | $25M | $177M |
How the market has priced INSP against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Inspire Medical Systems, Inc.'s revenue has grown 51.2% per year. These are computed facts, not advice.
As of FY2025, Inspire Medical Systems, Inc. reported — of total debt against $105M of cash; operating income covered interest expense 372×.
In FY2025, gross margin was 85.4%, operating margin 5.6%, and net margin 15.9%.
As of Jun '26, Inspire Medical Systems, Inc. traded at a price-to-earnings ratio of about 8.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.